Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc.) on July 31, 2013. The report announces the consolidated financial results for the fourth quarter and fiscal year 2013. The registrant is incorporated in Delaware with principal executive offices in Menlo Park, California.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. It only confirms that results for the fourth quarter and fiscal year 2013 were announced.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or details on unusual items. The report explicitly states that the information in Exhibit 99.1 is furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the correct registrant name is Landec Corporation, not Lifecore Biomedical, Inc.
- Review Exhibit 99.1 (Press Release dated July 31, 2013) for actual financial figures.
- Confirm the specific revenue and earnings per share for Q4 and FY 2013 in the attached press release.
- Check for any forward-looking statements or risk factors detailed in the press release.